alendronate has been researched along with Alzheimer Disease in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Zameer, S | 2 |
Alam, M | 1 |
Hussain, S | 2 |
Vohora, D | 2 |
Ali, J | 2 |
Najmi, AK | 1 |
Akhtar, M | 2 |
Kalam Najmi, A | 1 |
Casiano, V | 1 |
Kalish, VB | 1 |
Unwin, B | 1 |
Gibaldi, M | 1 |
1 review available for alendronate and Alzheimer Disease
Article | Year |
---|---|
Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?
Topics: Alendronate; Alzheimer Disease; Calcitonin; Calcium; Coronary Disease; Diphosphonates; Endometrial N | 1997 |
3 other studies available for alendronate and Alzheimer Disease
Article | Year |
---|---|
Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet.
Topics: Alendronate; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Diet, High-Fat; Female; Hip | 2020 |
Alendronate reduces the cognitive and neurological disturbances induced by combined doses of d-galactose and aluminum chloride in mice.
Topics: Alendronate; Aluminum Chloride; Alzheimer Disease; Animals; Cognitive Dysfunction; Female; Galactose | 2021 |
An unusual adverse event from a common medication in an individual with dementia.
Topics: Administration, Oral; Aged, 80 and over; Alendronate; Alzheimer Disease; Deglutition Disorders; Fema | 2014 |